The Genesis Prize is awarded annually to an extraordinary individual in recognition of outstanding professional achievement, contribution to humanity, and commitment to Jewish values

Launched in 2013, the prize is financed through a permanent endowment of $100 million established by The Genesis Prize Foundation (GPF).


The 2020 Genesis Prize Laureate, Jewish leader and activist Natan Sharansky, has chosen to gift the $1 million Genesis prize to 15 Non-Governmental Organizations and institutions in the humanitarian, social, scientific and medical fields working to mitigate the impact of coronavirus and advance recovery. 


In addition, Mr. Sharansky has initiated a special competition recognizing Israeli companies working to combat coronavirus and the damage of future pandemics. GPF, assisted by Start-Up Nation Central, will award prizes to Israeli companies that have made significant contributions to fighting COVID-19, or are working on promising technologies, therapies, or vaccines that have the potential to provide significant benefit in the near future.


All Israeli companies listed on the Start-Up Nation Finder Innovation Discovery Platform that are sporting the coronavirus tag, will automatically be included in this competition. A distinguished group of judges (names below) will shortlist 21 companies in seven categories. Of these, 10 finalists will be selected by a judging panel comprised of Laureate Natan Sharansky, Start-Up Nation Central CEO Prof. Eugene Kandel, and others. 


Winners of the competition will be announced at a festive event to be held in November 2020. The winning companies will donate their prize to a worthy NGO of their choice; the process will be led by Matan-United Way.


Applications are now closed! The shortlist will be announced on the 27th of September! 
Good luck to all the companies that submitted their entries. 

Panel of judges

  • Ruti Alon

    Founder and CEO, Medstrada VC

  • Neil Cohen 

    Chairman of Pembroke

    Assets Ltd

  • Yaron Daniely, Ph.D., MBA 

    Head of aMoon Alpha aMoon Ventures

  • Dr. Ora Dar, Ph.D. 

    Senior Expert, Medical Sciences & Health Innovation; national personalized

    medicine projects

  • Aimee Fisher

    Healthcare Investor and Advisor

  • Dr. Ariel Kor 

    Founder & Chairman, Israel Center on Addiction; Adj. Assistant Professor, School of Medicine, Yale University 

  • Netalie Nadivi

    Partner, Triventures

  • Lena Rogovin

    Senior Digital Health Analyst, Sector Lead. Start-Up Nation Central

  • Prof. Varda Shalev, MD

    Cofounder & CMO,


  • Emma Vardimon

    Senior Strategic Partnerships Manager, Start-Up Nation Central

  • Prof. Salman Zarka

    Director of the Ziv Medical Center in Safed

  • Dr. Eyal Zimlichman

    Deputy General Director; Chief Medical Officer; and Chief Innovation Officer, Sheba Medical Center

  • Prof. Eitan Friedman 

    Founder and director of the Oncogenetics Unit and the Meirav High-Risk Clinic, Sheba Medical Center, Tel Hashomer; Professor of Medicine, Sackler School of Medicine, Tel Aviv University Israel 


Proudly created by